Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Moore, Kathleen, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Banerjee, Susana, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William, Mathews, Cara, Liu, Joyce, Lowe, Elizabeth S, Bloomfield, Ralph, DiSilvestro, Paul
Published in The New England journal of medicine (27.12.2018)
Published in The New England journal of medicine (27.12.2018)
Get full text
Journal Article
Endometrial cancer
Makker, Vicky, MacKay, Helen, Ray-Coquard, Isabelle, Levine, Douglas A, Westin, Shannon N, Aoki, Daisuke, Oaknin, Ana
Published in Nature reviews. Disease primers (09.12.2021)
Published in Nature reviews. Disease primers (09.12.2021)
Get full text
Journal Article
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
Oza, Amit M, Prof, Cibula, David, Prof, Benzaquen, Ana Oaknin, MD, Poole, Christopher, Prof, Mathijssen, Ron H J, Prof, Sonke, Gabe S, MD, Colombo, Nicoletta, MD, Špaček, Jiří, MD, Vuylsteke, Peter, MD, Hirte, Holger, MD, Mahner, Sven, MD, Plante, Marie, MD, Schmalfeldt, Barbara, Prof, Mackay, Helen, MD, Rowbottom, Jacqui, PhD, Lowe, Elizabeth S, MD, Dougherty, Brian, PhD, Barrett, J Carl, PhD, Friedlander, Michael, Prof
Published in The lancet oncology (2015)
Published in The lancet oncology (2015)
Get full text
Journal Article
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, Krishnansu S, Sill, Michael W, Long, Harry J, Penson, Richard T, Huang, Helen, Ramondetta, Lois M, Landrum, Lisa M, Oaknin, Ana, Reid, Thomas J, Leitao, Mario M, Michael, Helen E, Monk, Bradley J
Published in The New England journal of medicine (20.02.2014)
Published in The New England journal of medicine (20.02.2014)
Get full text
Journal Article
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
Coleman, Robert L, Fleming, Gini F, Brady, Mark F, Swisher, Elizabeth M, Steffensen, Karina D, Friedlander, Michael, Okamoto, Aikou, Moore, Kathleen N, Efrat Ben-Baruch, Noa, Werner, Theresa L, Cloven, Noelle G, Oaknin, Ana, DiSilvestro, Paul A, Morgan, Mark A, Nam, Joo-Hyun, Leath, Charles A, Nicum, Shibani, Hagemann, Andrea R, Littell, Ramey D, Cella, David, Baron-Hay, Sally, Garcia-Donas, Jesus, Mizuno, Mika, Bell-McGuinn, Katherine, Sullivan, Danielle M, Bach, Bruce A, Bhattacharya, Sudipta, Ratajczak, Christine K, Ansell, Peter J, Dinh, Minh H, Aghajanian, Carol, Bookman, Michael A
Published in The New England journal of medicine (19.12.2019)
Published in The New England journal of medicine (19.12.2019)
Get full text
Journal Article
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
Naumann, R Wendel, Hollebecque, Antoine, Meyer, Tim, Devlin, Michael-John, Oaknin, Ana, Kerger, Joseph, López-Picazo, Jose M, Machiels, Jean-Pascal, Delord, Jean-Pierre, Evans, Thomas R J, Boni, Valentina, Calvo, Emiliano, Topalian, Suzanne L, Chen, Tian, Soumaoro, Ibrahima, Li, Bin, Gu, Junchen, Zwirtes, Ricardo, Moore, Kathleen N
Published in Journal of clinical oncology (01.11.2019)
Published in Journal of clinical oncology (01.11.2019)
Get full text
Journal Article
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Swisher, Elizabeth M, Dr Prof, Lin, Kevin K, PhD, Oza, Amit M, Prof, Scott, Clare L, PhD, Giordano, Heidi, MA, Sun, James, PhD, Konecny, Gottfried E, MD, Coleman, Robert L, Prof, Tinker, Anna V, MD, O'Malley, David M, MD, Kristeleit, Rebecca S, MD, Ma, Ling, MD, Bell-McGuinn, Katherine M, MD, Brenton, James D, Prof, Cragun, Janiel M, MD, Oaknin, Ana, MD, Ray-Coquard, Isabelle, Prof, Harrell, Maria I, PhD, Mann, Elaina, MS, Kaufmann, Scott H, Prof, Floquet, Anne, MD, Leary, Alexandra, MD, Harding, Thomas C, PhD, Goble, Sandra, MS, Maloney, Lara, BA, Isaacson, Jeff, PhD, Allen, Andrew R, MD, Rolfe, Lindsey, MBChB, Yelensky, Roman, PhD, Raponi, Mitch, PhD, McNeish, Iain A, Prof
Published in The lancet oncology (2017)
Published in The lancet oncology (2017)
Get full text
Journal Article
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression
Lheureux, Stephanie, Oaknin, Ana, Garg, Swati, Bruce, Jeffrey P, Madariaga, Ainhoa, Dhani, Neesha C, Bowering, Valerie, White, Justin, Accardi, Sarah, Tan, Qian, Braunstein, Marsela, Karakasis, Katherine, Cirlan, Iulia, Pedersen, Stephanie, Li, Tiantiam, Fariñas-Madrid, Lorena, Lee, Yeh Chen, Liu, Zhihui Amy, Pugh, Trevor J, Oza, Amit M
Published in Clinical cancer research (15.08.2020)
Published in Clinical cancer research (15.08.2020)
Get full text
Journal Article
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Elkabets, Moshe, Pazarentzos, Evangelos, Juric, Dejan, Sheng, Qing, Pelossof, Raphael A., Brook, Samuel, Benzaken, Ana Oaknin, Rodon, Jordi, Morse, Natasha, Yan, Jenny Jiacheng, Liu, Manway, Das, Rita, Chen, Yan, Tam, Angela, Wang, Huiqin, Liang, Jinsheng, Gurski, Joseph M., Kerr, Darcy A., Rosell, Rafael, Teixidó, Cristina, Huang, Alan, Ghossein, Ronald A., Rosen, Neal, Bivona, Trever G., Scaltriti, Maurizio, Baselga, José
Published in Cancer cell (13.04.2015)
Published in Cancer cell (13.04.2015)
Get full text
Journal Article
BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Lin, Kevin K, Harrell, Maria I, Oza, Amit M, Oaknin, Ana, Ray-Coquard, Isabelle, Tinker, Anna V, Helman, Elena, Radke, Marc R, Say, Carmen, Vo, Lan-Thanh, Mann, Elaina, Isaacson, Jeffrey D, Maloney, Lara, O'Malley, David M, Chambers, Setsuko K, Kaufmann, Scott H, Scott, Clare L, Konecny, Gottfried E, Coleman, Robert L, Sun, James X, Giordano, Heidi, Brenton, James D, Harding, Thomas C, McNeish, Iain A, Swisher, Elizabeth M
Published in Cancer discovery (01.02.2019)
Published in Cancer discovery (01.02.2019)
Get full text
Journal Article
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study
Oaknin, Ana, Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O’Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda, Ghamande, Sharad, Ghatage, Prafull, Kristeleit, Rebecca, Leath III, Charles, Guo, Wei, Im, Ellie, Zildjian, Sybil, Han, Xinwei, Duan, Tao, Veneris, Jennifer, Pothuri, Bhavana
Published in Journal for immunotherapy of cancer (01.01.2022)
Published in Journal for immunotherapy of cancer (01.01.2022)
Get full text
Journal Article
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
Audeh, M William, Dr, Carmichael, James, Prof, Penson, Richard T, MD, Friedlander, Michael, Prof, Powell, Bethan, Prof, Bell-McGuinn, Katherine M, PhD, Scott, Clare, MD, Weitzel, Jeffrey N, Prof, Oaknin, Ana, MD, Loman, Niklas, MD, Lu, Karen, Prof, Schmutzler, Rita K, Prof, Matulonis, Ursula, MD, Wickens, Mark, BSc, Tutt, Andrew, PhD
Published in The Lancet (British edition) (24.07.2010)
Published in The Lancet (British edition) (24.07.2010)
Get full text
Journal Article
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Swisher, Elizabeth M, Kwan, Tanya T, Oza, Amit M, Tinker, Anna V, Ray-Coquard, Isabelle, Oaknin, Ana, Coleman, Robert L, Aghajanian, Carol, Konecny, Gottfried E, O'Malley, David M, Leary, Alexandra, Provencher, Diane, Welch, Stephen, Chen, Lee-May, Wahner Hendrickson, Andrea E, Ma, Ling, Ghatage, Prafull, Kristeleit, Rebecca S, Dorigo, Oliver, Musafer, Ashan, Kaufmann, Scott H, Elvin, Julia A, Lin, Douglas I, Chambers, Setsuko K, Dominy, Erin, Vo, Lan-Thanh, Goble, Sandra, Maloney, Lara, Giordano, Heidi, Harding, Thomas, Dobrovic, Alexander, Scott, Clare L, Lin, Kevin K, McNeish, Iain A
Published in Nature communications (03.05.2021)
Published in Nature communications (03.05.2021)
Get full text
Journal Article
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
Romero, Octavio A., Vilarrubi, Andrea, Alburquerque-Bejar, Juan J., Gomez, Antonio, Andrades, Alvaro, Trastulli, Deborah, Pros, Eva, Setien, Fernando, Verdura, Sara, Farré, Lourdes, Martín-Tejera, Juan F., Llabata, Paula, Oaknin, Ana, Saigi, Maria, Piulats, Josep M., Matias-Guiu, Xavier, Medina, Pedro P., Vidal, August, Villanueva, Alberto, Sanchez-Cespedes, Montse
Published in Nature communications (14.07.2021)
Published in Nature communications (14.07.2021)
Get full text
Journal Article
Advances in immunotherapy for cervical cancer
Grau-Bejar, Juan Francisco, Garcia-Duran, Carmen, Garcia-Illescas, David, Mirallas, Oriol, Oaknin, Ana
Published in Therapeutic Advances in Medical Oncology (01.01.2023)
Published in Therapeutic Advances in Medical Oncology (01.01.2023)
Get full text
Book Review
Journal Article
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
Poveda, Andres, Oaknin, Ana, Romero, Ignacio, Guerrero-Zotano, Angel, Fariñas-Madrid, Lorena, Rodriguez-Freixinos, Victor, Mallol, Pedro, Lopez-Reig, Raquel, Lopez-Guerrero, Jose Antonio
Published in Scientific reports (24.02.2021)
Published in Scientific reports (24.02.2021)
Get full text
Journal Article
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
Monk, Bradley J, Prof, Poveda, Andrés, MD, Vergote, Ignace, MD, Raspagliesi, Francesco, MD, Fujiwara, Keiichi, MD, Bae, Duk-Soo, MD, Oaknin, Ana, MD, Ray-Coquard, Isabelle, MD, Provencher, Diane M, MD, Karlan, Beth Y, MD, Lhommé, Catherine, MD, Richardson, Gary, MD, Rincón, Dolores Gallardo, MD, Coleman, Robert L, MD, Herzog, Thomas J, MD, Marth, Christian, PhD, Brize, Arija, MD, Fabbro, Michel, MD, Redondo, Andrés, MD, Bamias, Aristotelis, PhD, Tassoudji, Marjan, MS, Navale, Lynn, MS, Warner, Douglas J, MD, Oza, Amit M, MD
Published in The lancet oncology (01.07.2014)
Published in The lancet oncology (01.07.2014)
Get full text
Journal Article
Treatment of metastatic cervical cancer: Future directions involving targeted agents
Diaz-Padilla, Ivan, Monk, Bradley J, Mackay, Helen J, Oaknin, Ana
Published in Critical reviews in oncology/hematology (01.03.2013)
Published in Critical reviews in oncology/hematology (01.03.2013)
Get full text
Journal Article
Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
MONK, Bradley J, MAS LOPEZ, Luis, ZARBA, Juan J, OAKNIN, Ana, TARPIN, Carole, TERMRUNGRUANGLERT, Wichai, ALBER, Jacquelyn A, JIE DING, STUTTS, Melissa W, PANDITE, Lini N
Published in Journal of clinical oncology (01.08.2010)
Published in Journal of clinical oncology (01.08.2010)
Get full text
Journal Article
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)
Penson, Richard T, Prof, Huang, Helen Q, MS, Wenzel, Lari B, Prof, Monk, Bradley J, Prof, Stockman, Sharon, BA, Long, Harry J, Prof, Ramondetta, Lois M, MD, Landrum, Lisa M, PhD, Oaknin, Ana, MD, Reid, Thomas J A, MD, Leitao, Mario M, MD, Method, Michael, MD, Michael, Helen, Prof, Tewari, Krishnansu S, Prof
Published in The lancet oncology (01.03.2015)
Published in The lancet oncology (01.03.2015)
Get full text
Journal Article